Aptahem AB Sustainability Reports
Aptahem AB is a clinical-stage biotechnology company that develops aptamer-based RNA pharmaceuticals. Its lead candidate, Apta-1, is designed as an emergency medicine to treat acute, life-threatening conditions such as sepsis.
Sector: Manufacturing
Country: Sweden
Exchange: Nordic Growth Market
LEI: 549300IVD1BY4CJMSO40
FIGI: BBG008GSTL69
4 reports from 2014 to 2025
